LATE-NC in Alzheimer's disease: Molecular aspects and synergies

被引:5
|
作者
Tome, Sandra O. [1 ,2 ]
Gawor, Klara [1 ,2 ]
Thal, Dietmar Rudolf [1 ,2 ,3 ]
机构
[1] Katholieke Univ Leuven, Dept Imaging & Pathol, Lab Neuropathol, Leuven, Belgium
[2] Katholieke Univ Leuven, Leuven Brain Inst, Leuven, Belgium
[3] Univ Hosp Leuven, Dept Pathol, Leuven, Belgium
关键词
Alzheimer's disease; LATE-NC; tau; TDP-43; DNA-BINDING PROTEIN; FRONTOTEMPORAL LOBAR DEGENERATION; HIPPOCAMPAL SCLEROSIS; TDP-43; PATHOLOGY; COGNITIVE DECLINE; BRAIN-REGIONS; DEMENTIA; TAU; ENCEPHALOPATHY; IMMUNOREACTIVITY;
D O I
10.1111/bpa.13213
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Alzheimer's disease (AD) is classically characterized by senile plaques and neurofibrillary tangles (NFTs). However, multiple copathologies can be observed in the AD brain and contribute to the development of cognitive decline. Limbic-predominant age-related TDP-43 encephalopathy neuropathological changes (LATE-NC) accumulates in the majority of AD cases and leads to more severe cognitive decline compared with AD pathology alone. In this review, we focus on the synergistic relationship between LATE-NC and tau in AD, highlighting the aggravating role of TDP-43 aggregates on tau pathogenesis and its impact on the clinical picture and therapeutic strategies. Additionally, we discuss to what extent the molecular patterns of LATE-NC in AD differ from frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP) neuropathological changes. Thus, we highlight the importance of tau and TDP-43 synergies for subtyping AD patients, which may respond differently to therapeutic interventions depending on the presence of comorbid LATE-NC.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] In vivo effect of LATE-NC on integrity of white matter connections to the hippocampus
    Heywood, Ashley
    Stocks, Jane
    Schneider, Julie A.
    Arfanakis, Konstantinos
    Bennett, David A.
    Beg, Mirza Faisal
    Wang, Lei
    ALZHEIMERS & DEMENTIA, 2024, 20 (07) : 4401 - 4410
  • [22] New criteria to predict LATE-NC in the clinical setting: Probable/Possible LATE and LANS
    Nelson, Peter T.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2024,
  • [23] LATE-NC and hippocampal sclerosis: Coherent patterns and consequences of pathological progression
    Nelson, Peter
    Dugan, Adam
    Katsumata, Yuriko
    Cykowski, Matthew
    Schneider, Julie
    Kukull, Walter
    Gauthreaux, Kathryn
    Fardo, David
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2022, 81 (06): : 468 - 468
  • [24] Pure LATE-NC: Frequency, clinical impact, and the importance of considering APOE genotype when assessing this and other subtypes of non-Alzheimer's pathologies
    Katsumata, Yuriko
    Wu, Xian
    Aung, Khine Zin
    Fardo, David W.
    Woodworth, Davis C.
    Sajjadi, S. Ahmad
    Tome, Sandra O.
    Thal, Dietmar Rudolf
    Troncoso, Juan C.
    Chang, Koping
    Mock, Charles
    Nelson, Peter T.
    ACTA NEUROPATHOLOGICA, 2024, 148 (01)
  • [25] Molecular aspects of inflammatory and immune responses in Alzheimer's disease
    Kalaria, RN
    HarshbargerKelly, M
    Cohen, DL
    Premkumar, DRD
    NEUROBIOLOGY OF AGING, 1996, 17 (05) : 687 - 693
  • [26] Molecular genetics of late-onset Alzheimer's disease
    Kamboh, MI
    ANNALS OF HUMAN GENETICS, 2004, 68 : 381 - 404
  • [27] The Role of Vascular Factors in Late-Onset Sporadic Alzheimer's Disease. Genetic and Molecular Aspects
    Rocchi, A.
    Orsucci, D.
    Tognoni, G.
    Ceravolo, R.
    Siciliano, G.
    CURRENT ALZHEIMER RESEARCH, 2009, 6 (03) : 224 - 237
  • [28] A pathologic study of Perivascular pTDP-43 Lin bodies in LATE-NC
    Shahidehpour, Ryan K.
    Nelson, Peter T.
    Bachstetter, Adam D.
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2024, 12 (01):
  • [29] Evaluating the updated LATE-NC staging criteria using data from NACC
    Woodworth, Davis C.
    Nguyen, Katelynn M.
    Sordo, Lorena
    Scambray, Kiana A.
    Head, Elizabeth
    Kawas, Claudia H.
    Corrada, Maria M.
    Nelson, Peter T.
    Sajjadi, S. Ahmad
    ALZHEIMERS & DEMENTIA, 2024, 20 (12) : 8359 - 8373
  • [30] Alzheimer's Disease in the Down Syndrome: An Overview of Genetics and Molecular Aspects
    Gomes, Fabiana de C.
    Mattos, Marlon F.
    Goloni-Bertollo, Eny M.
    Pavarino, Erika C.
    NEUROLOGY INDIA, 2021, 69 (01) : 32 - 41